← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Hospital For Special Surgery
New York, NY
$245,091,072
Total funding
174
Grants
Funding over time
peak $18.7M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$244,341,072 · 171
NSF$400,001 · 1
AHRQ$349,999 · 2
By mechanism
R01$196,158,982 · 79
T32$7,971,565 · 4
R21$6,795,248 · 17
P30$4,533,851 · 12
RC4$4,140,386 · 1
K23$2,874,893 · 7
Investigators at Hospital For Special Surgery
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
Defining Common Molecular Parameters For Onset and Progression of Osteoarthritis$4,140,386
RC4 · FY2010 · AR
Activation of Macrophages in Human Autoimmune Diseases$3,071,328
R01 · FY2025 · AI
Predictors of Pregnancy Outcome In SLE and APS$1,404,726
R01 · FY2008 · AR
Predictors of Pregnancy Outcome In SLE and APS$1,271,869
R01 · FY2009 · AR
Predictors of Pregnancy Outcome In SLE and APS$1,260,461
R01 · FY2010 · AR
Predictors of Pregnancy Outcome In SLE and APS$1,244,577
R01 · FY2011 · AR
Predictors of Pregnancy Outcome In SLE and APS$1,213,915
R01 · FY2012 · AR
Predictors of Pregnancy Outcome in SLE and APS$1,191,499
R01 · FY2005 · AR
Predictors of Pregnancy Outcome in SLE and APS$1,167,785
R01 · FY2004 · AR
Consortium for Translational Research in Marfan Syndrome$1,162,321
P01 · FY2005 · AR
Predictors of Pregnancy Outcome in SLE and APS$1,145,424
R01 · FY2003 · AR
Consortium for Translational Research in Marfan Syndrome$1,129,857
P01 · FY2004 · AR
Predictors of Pregnancy Outcome in SLE and APS$1,096,742
R01 · FY2006 · AR
Predictors of Pregnancy Outcome in SLE and APS$1,089,221
R01 · FY2007 · AR
Functional consequences of intergenic autoimmune disease risk variants$883,641
R01 · FY2023 · AI
Functional consequences of intergenic autoimmune disease risk variants$848,882
R01 · FY2024 · AI
Functional consequences of intergenic autoimmune disease risk variants$807,441
R01 · FY2025 · AI
Langerhans cells and lymphatic regulation in immunity$788,508
R01 · FY2024 · AR
FT-IR Microscopy of Mineral Structure$772,801
R01 · FY2010 · AR
Magnetic Resonance Imaging as a Biomarker For Adverse Local Tissue Reaction In In$750,507
R01 · FY2013 · AR